Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Large, International, Randomized, Placebo-controlled Trial to Assess the Impact of Dabigatran (a Direct Thrombin Inhibitor) and Omeprazole (a Proton-pump Inhibitor) in Patients Suffering Myocardial Injury After Noncardiac Surgery

NCT01661101 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT01661101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01661101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Large, International, Randomized, Placebo-controlled Trial to Assess the Impact of Dabigatran (a Direct Thrombin Inhibitor) and Omeprazole (a Proton-pump Inhibitor) in Patients Suffering Myocardial Injury After Noncardiac Surgery
Lead sponsor
Population Health Research Institute
Phase
Phase 3
Overall status
Completed
Start date
January 31, 2013
Completion date
March 1, 2018
Enrollment
1,754 (actual)
Sites
82

Conditions

As the registry lists them; a condition with its own page is linked.

myocardial injury after noncardiac surgery (mins)